ATAI Life Sciences partners with Neuronasal to develop concussion treatment

pharmanewsdaily- January 7, 2020 0

ATAI Life Sciences, a German biotech company focused on developing drugs for mental illnesses, has partnered with Neuronasal to develop a short-term treatment for mild ... Read More

Prevacus partners with Blinktbi for advanced concussion drug trials

pharmanewsdaily- July 15, 2018 0

Prevacus, a leading US biopharmaceutical company, has announced a strategic partnership with medical device company Blinktbi, utilizing their novel EyeStat device to measure brain function ... Read More